Ciclosporin no better than infliximab for acute refractory ulcerative colitis

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e6923 (Published 17 October 2012)
Cite this as: BMJ 2012;345:e6923

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

High dose intravenous corticosteroids are the first line treatment for people with a severe exacerbation of ulcerative colitis. When steroids can’t control an acute episode, doctors can choose between ciclosporin and infliximab as rescue treatments, say researchers. Patients responded equally well to both drugs in the first head …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL